AKT1 and non-small cell lung carcinoma: Genomic alterations (mutation, rearrangement, amplification) in NSCLC include (Epidermal growth factor receptor) EGFR, ALK, ROS1, RET, BRAF, FGFR-1, MET, DDR2, PIK3C, AKT, and PTEN (Table 1).